Delivery Order SPE2DB20D2104-SPE2DB22FS37Y

Award Date 4/11/22
Potential Completion Date 4/12/22
Potential Value $2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,104.48, is for the delivery of the pharmaceutical product Junel FE 1 mg-20 mcg tablet in packages of 28. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,506.61 Firm Fixed Price Delivery Order contract covers the supply of JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.88 Firm Fixed Price Delivery Order covers the supply of the pharmaceutical product "JUNEL FE 1 MG-20 MCG TABLET 28S" with a completion date of December 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,285.66 firm fixed price delivery order contract is for the supply of the contraceptive drug Junel FE 1 mg-20 mcg tablets. The contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565285668 JUNEL FE 1 MG-20 MCG TABLET 28S. The $1,670.88 firm fixed-price delivery order contract has a completion date of July 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,488.06 Firm Fixed Price Delivery Order contract is for the supply of JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 7, 2025. While the award is not associated with a set-aside, Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,860.86 Firm Fixed Price Delivery Order is for the supply of JUNEL FE 1 MG-20 MCG TABLET 28S medical products. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued by the Defense Logistics Agency (DLA) worth $2,388.74. The contract is for 4556527340 ! JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product, with a period of performance ending on March 11, 2022. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,344.85 firm fixed-price delivery order is for the supply of JUNEL 1.5 MG-30 MCG TABLET 21S, a medical commodity. The contract has an ultimate completion date of September 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Junel FE 1 mg-20 mcg tablets. The contract, valued at $1,848.91, is a Firm Fixed Price Delivery Order that will be completed by April 28, 2023. This award is not designated with a set-aside and reflects an open competition. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor, has a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FS37Y
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,017.08 firm-fixed-price delivery order is for the pharmaceutical product "JUNEL FE 1 MG-20 MCG TABLET 28S" and has an ultimate completion date of April 12, 2022.

Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

The contract award did not utilize any set-aside designations, indicating full and open competition. Amerisourcebergen's extensive experience in federal healthcare contracting and its ability to efficiently fulfill a wide range of pharmaceutical and medical supply needs for the Department of Defense and other government agencies are demonstrated by these contract awards.

Generated 2/27/25, 10:55 AM